These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 17261152)
1. Activated protein C (Xigris): a drug in trouble. Vangerow B; Mignini MA Acta Anaesthesiol Scand; 2007 Feb; 51(2):261-2. PubMed ID: 17261152 [No Abstract] [Full Text] [Related]
2. Activated protein C (Xigris) treatment in sepsis: a drug in trouble. Gårdlund B Acta Anaesthesiol Scand; 2006 Sep; 50(8):907-10. PubMed ID: 16923083 [TBL] [Abstract][Full Text] [Related]
3. [Xigris--activated protein C]. Tønnesen EK Ugeskr Laeger; 2004 Mar; 166(11):1002-4. PubMed ID: 15049235 [No Abstract] [Full Text] [Related]
4. [Xigris and corticoids: what are the perspectives for the patient with severe sepsis?]. Annane D Ann Fr Anesth Reanim; 2003 Dec; 22 Spec No 1():43-5. PubMed ID: 15359943 [No Abstract] [Full Text] [Related]
5. Xigris: reducing mortality in adult patients with severe sepsis. Larson AM Urol Nurs; 2002 Jun; 22(3):200-1. PubMed ID: 12087796 [No Abstract] [Full Text] [Related]
6. The search for effective therapy for sepsis: back to the drawing board? Angus DC JAMA; 2011 Dec; 306(23):2614-5. PubMed ID: 22187284 [No Abstract] [Full Text] [Related]
7. Risks and benefits of activated protein C treatment for severe sepsis. Warren HS; Suffredini AF; Eichacker PQ; Munford RS N Engl J Med; 2002 Sep; 347(13):1027-30. PubMed ID: 12324562 [No Abstract] [Full Text] [Related]
8. The Sepsis Saga: Consensus to Xigris. Dries DJ Air Med J; 2016; 35(4):194-6. PubMed ID: 27393750 [No Abstract] [Full Text] [Related]
9. [Clinical experience with xigris]. Wyncoll D Ann Fr Anesth Reanim; 2003 Dec; 22 Spec No 1():46-7. PubMed ID: 15359944 [No Abstract] [Full Text] [Related]
10. Criteria for use of drotrecogin alfa. Jacobi J Am J Health Syst Pharm; 2004 Jan; 61(2):203-4; author reply 204-5. PubMed ID: 14750407 [No Abstract] [Full Text] [Related]
11. [Clinical approach to the identification of patients suffering from severe sepsis with several organ failures for the administration of drotrecogin alfa (activated): from the PROWESS study to clinical practice]. Dhainaut JF; Payen DM; Bernardin G; Gérard JL; Martin C; Perrotin D; Regnier B Ann Fr Anesth Reanim; 2003 Dec; 22 Spec No 1():53-64. PubMed ID: 15359946 [No Abstract] [Full Text] [Related]
12. Drotrecogin alfa (activated) in severe sepsis. Friedrich JO N Engl J Med; 2006 Jan; 354(1):94-6; author reply 94-6. PubMed ID: 16394311 [No Abstract] [Full Text] [Related]
13. Severe sepsis and therapy with activated protein C. Parrillo JE N Engl J Med; 2005 Sep; 353(13):1398-400. PubMed ID: 16192486 [No Abstract] [Full Text] [Related]
14. Assessing the use of activated protein C in the treatment of severe sepsis. Siegel JP N Engl J Med; 2002 Sep; 347(13):1030-4. PubMed ID: 12324563 [No Abstract] [Full Text] [Related]
15. Targeting the coagulation cascade in sepsis: did we find the "magic bullet"? Mathiak G; Neville LF; Grass G Crit Care Med; 2003 Jan; 31(1):310-1. PubMed ID: 12545036 [No Abstract] [Full Text] [Related]
16. How to ENHANCE our knowledge of activated protein C during pediatric sepsis trials: pediatric versus adult trials. Hazelzet JA Pediatr Crit Care Med; 2006 May; 7(3):277-8. PubMed ID: 16682888 [No Abstract] [Full Text] [Related]
17. [Recombinant activated protein C: from evidence to clinical practice. Clinical practice guidelines for the use of activated proteins C in the treatment of severe sepsis]. Heslet L; Nielsen JD; Schierbeck J; Andersen JS Ugeskr Laeger; 2004 Mar; 166(11):997-1002. PubMed ID: 15049234 [No Abstract] [Full Text] [Related]
18. Treatment of severe sepsis with Xigris: implications for the clinical nurse specialist. Powers J; Jacobi J Clin Nurse Spec; 2003 May; 17(3):128-30. PubMed ID: 12792186 [No Abstract] [Full Text] [Related]
19. [Questionable efficacy and safety of activated drotrecogin alpha (activated protein C) in the treatment of severe sepsis]. Girbes AR; Polderman KH; Beishuizen A; van Zanten AR; Schultz MJ Ned Tijdschr Geneeskd; 2006 Jun; 150(22):1265-6; author reply 1266. PubMed ID: 16796179 [No Abstract] [Full Text] [Related]
20. Drotrecogin alfa (activated) in severe sepsis. LaRosa SP N Engl J Med; 2006 Jan; 354(1):94-6; author reply 94-6. PubMed ID: 16395833 [No Abstract] [Full Text] [Related] [Next] [New Search]